Related Experiment Video
Updated: Jun 24, 2026
09:31
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Flow cytometric immunophenotyping of peripheral T cell neoplasms using CD3 gating
Satoshi Hara1, Taiji Yokote, Toshikazu Akioka
1Department of Internal Medicine (I), Osaka Medical College, Osaka, Japan. in1211@poh.osaka-med.ac.jp
Acta Haematologica
|March 17, 2009
Summary
Diagnosing peripheral T cell neoplasms (PTCNs) is challenging. CD3 gating in flow cytometry effectively distinguishes abnormal T cells from normal ones, aiding in early PTCN diagnosis and treatment.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Peripheral T cell neoplasms (PTCNs) have poorer prognoses than B cell neoplasms.
- Accurate and early diagnosis of PTCNs is crucial for effective treatment.
- Diagnosing PTCNs can be diagnostically challenging.
Purpose of the Study:
- To evaluate the utility of flow cytometric immunophenotyping with CD3 gating for diagnosing PTCNs.
- To compare flow cytometry data with immunohistochemical findings in PTCN patients.
Main Methods:
- Retrospective analysis of 56 samples from 52 patients diagnosed with PTCNs.
- Flow cytometric immunophenotyping was performed using CD3 gating.
- Analytical data were compared with immunohistochemical findings.
Main Results:
- Abnormal CD3 T cell populations were successfully distinguished from normal T cell populations.
- The CD3 gating strategy proved effective in identifying aberrant T cell populations.
- Flow cytometry findings correlated with immunohistochemical results.
Conclusions:
- CD3 gating in flow cytometry is a valuable tool for the accurate and early diagnosis of PTCNs.
- This method aids in differentiating neoplastic T cells from normal T cells.
- Improved diagnostic accuracy can lead to better patient outcomes for PTCNs.
